MoneyWorks4Me

Gland Pharma informs about analyst meet

27 Jan 2023 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting with the Company to be held on 27th January 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.40
Dr. Reddys Labs. 1231.15
Cipla 1306.20
Lupin 1944.30
Zydus Lifesciences 1121.60
View more..